Watson N V, Gorzalka B B
University of British Columbia, Vancouver, Canada.
Pharmacol Biochem Behav. 1991 Jul;39(3):605-12. doi: 10.1016/0091-3057(91)90135-o.
Relatively little is known regarding the role of 5-HT2 receptor activity in male rat sexual behavior. Previous work has yielded equivocal results, and both facilitation and inhibition of copulation have been reported to follow administration of selective 5-HT2 antagonists. In the present series of experiments, the ability of a variety of 5-HT2 antagonists to block inhibition induced by the 5-HT2/5-HT1C agonist DOI was examined. Systemic ritanserin, pirenperone and ketanserin all potently blocked DOI-induced (1.0 mg/kg SC) inhibition of mounts, intromissions and ejaculations. None of these drugs influenced the sexual behavior of the male rats when given alone in doses that effectively blocked DOI-induced inhibition. In addition, unlike ritanserin and ketanserin, pirenperone produced a biphasic effect on DOI-induced inhibition, exhibiting a diminished blockade at higher doses. This may be due to activity at receptors other than 5-HT2. Overall, the present data suggest that activity at 5-HT2 receptors mediates an inhibition of male rat sexual behavior.
关于5-羟色胺2(5-HT2)受体活性在雄性大鼠性行为中的作用,人们所知相对较少。先前的研究得出了矛盾的结果,据报道,给予选择性5-HT2拮抗剂后,交配行为既有促进作用,也有抑制作用。在本系列实验中,研究了多种5-HT2拮抗剂阻断由5-HT2/5-HT1C激动剂DOI诱导的抑制作用的能力。全身给予利坦色林、哌仑西平和酮色林均能有效阻断DOI(1.0毫克/千克皮下注射)诱导的爬跨、插入和射精抑制。当以有效阻断DOI诱导抑制的剂量单独给予这些药物时,没有一种药物会影响雄性大鼠的性行为。此外,与利坦色林和酮色林不同,哌仑西平对DOI诱导的抑制产生双相效应,在较高剂量时表现出阻断作用减弱。这可能是由于其对5-HT2以外的受体有活性。总体而言,目前的数据表明,5-HT2受体的活性介导了对雄性大鼠性行为的抑制。